50 Results for "

NSC 20116

" in MedChemExpress (MCE) Product Catalog:
Products (50)

50 Results for "NSC 20116" in MCE Product Catalog:

Cat. No.: HY-168344
CAS No.: 1030781-08-8
Target:  

Adrenergic Receptor

Research Areas:  

Inflammation/Immunology

CACPD2011a-0001278239 is a β2AR mixed agonist that shows a wide range of high-affinity binding to both wild-type and T164I β2AR variants, with no cytotoxicity or mutagenicity, making it suitable for asthma research .
loading...
    loading...
Cat. No.: HY-114705
CAS No.: 787-93-9
Synonyms: LY-201116; ADD 75073
Target:  

Drug Derivative

Research Areas:  

Neurological Disease

Ameltolide (LY-201116; ADD 75073) is a novel anticonvulsant agent and can be used for epilepsy research .
loading...
    loading...
Cat. No.: HY-50898C
CAS No.: 1187538-35-7
Synonyms: GW572016 tosylate; GW2016 tosylate
Target:  

EGFR Ferroptosis Autophagy

Research Areas:  

Cancer

Lapatinib (GW572016) tosylate is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
Cat. No.: HY-B1558
CAS No.: 90293-01-9
Synonyms: MCI-2016 free base
Target:  

Calcium Channel

Research Areas:  

Neurological Disease

Bifemelane is a nootropic compound. Bifemelan causes the first peak by stimulating release from intracellular Ca 2+ stores and the second by capacitive entry through store–operated Ca 2+ channels. Bifemelane will be provided as a pharmacological tool for basic studies on astrocytes .
loading...
    loading...
Cat. No.: HY-76772A
Synonyms: (+)-SNI-2011; (+)-AF102B hydrochloride hemihydrate
Target:  

mAChR

Research Areas:  

Neurological Disease

(+)-Cevimeline hydrochloride hemihydrate ((+)-SNI-2011), a potent muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome.
loading...
    loading...
Cat. No.: HY-76772B
Synonyms: (-)-SNI-2011; (-)-AF102B hydrochloride hemihydrate
Target:  

mAChR

Research Areas:  

Neurological Disease

(-)-Cevimeline hydrochloride hemihydrate ((-)-SNI-2011), a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome.
loading...
    loading...
Cat. No.: HY-164399A
CAS No.: 1202920-93-1
Target:  

HSP ERK CDK Akt

Research Areas:  

Cancer

SST0116CL1 free base is a HSP90 inhibitor (IC50: 0.21 μM). SST0116CL1 free base binds to the ATP binding pocket of Hsp90, and interferes with Hsp90 chaperone function thus resulting in client protein (EGFR, CDK4 and AKT) degradation. SST0116CL1 free base induces degradation of Her2 in BT-474 cell (IC50: 0.2 μM). SST0116CL1 free base has antiproliferative activity and inhibits tumor growth. SST0116CL1 free base has antiproliferative activity and inhibits tumor growth. SST0116CL1 free base can be used for the study of leukemia, gastric and ovarian carcinoma .
loading...
    loading...
Cat. No.: HY-R00439
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-2116-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
loading...
    loading...
Cat. No.: HY-R00440
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-2116-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
loading...
    loading...
Cat. No.: HY-50898R
CAS No.: 231277-92-2
Synonyms: GW572016 (Standard); GW2016 (Standard)
Research Areas:  

Cancer

Lapatinib (Standard) is the analytical standard of Lapatinib. This product is intended for research and analytical applications. Lapatinib (GW572016) is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
Cat. No.: HY-50898BR
CAS No.: 388082-78-8
Synonyms: GW572016 ditosylate monohydrate (Standard); GW2016 ditosylate monohydrate (Standard)
Research Areas:  

Cancer

Lapatinib (ditosylate monohydrate) (Standard) is the analytical standard of Lapatinib (ditosylate monohydrate). This product is intended for research and analytical applications. Lapatinib ditosylate monohydrate (GW572016 ditosylate monohydrate) is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
Cat. No.: HY-50898AR
CAS No.: 388082-77-7
Synonyms: GW572016 ditosylate (Standard); GW2016 ditosylate (Standard)
Research Areas:  

Cancer

Lapatinib (ditosylate) (Standard) is the analytical standard of Lapatinib (ditosylate). This product is intended for research and analytical applications. Lapatinib ditosylate (GW572016 ditosylate) is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
Cat. No.: HY-50898CS
CAS No.: 2749856-05-9
Synonyms: GW572016-d4 tosylate; GW2016-d4 tosylate
Research Areas:  

Cancer

Lapatinib-d4 (GW572016-d4) tosylate is deuterium labeled Lapatinib (tosylate). Lapatinib (GW572016) tosylate is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
Cat. No.: HY-50898S2
CAS No.: 2748212-14-6
Synonyms: GW572016-d5; GW2016-d5
Lapatinib-d5 is deuterium labeled Lapatinib. Lapatinib (GW572016) is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
Cat. No.: HY-164353
CAS No.: 2959475-51-3
Target:  

ADC Linkers

Research Areas:  

Cancer

HX20111 is an ADC linker, and can be used for synthesis of ADCs .
loading...
    loading...
Cat. No.: HY-P811641

Host:  

Mouse

Application:  

WB, ICC/IF

Reactivity:  

Species independent

loading...
    loading...
Cat. No.: HY-P991528

Target:  

NF-κB

Research Areas:  

Inflammation/Immunology Cancer

PE0116 is a fully human CD137 agonistic monoclonal antibody generated from immunized harbor H2L2 human transgenic mice. PE0116 is a ligand block. PE0116 activates NF-κB signaling which significantly promotes T-cell proliferation and increases cytokine secretion in vitro. PE0116 exhibits robust antitumor activity in MC38 tumor model .
loading...
    loading...
Cat. No.: HY-P88429
Synonyms: FLJ20516

Host:  

Mouse

Application:  

IHC-P

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P88429A
Synonyms: FLJ20516

Host:  

Mouse

Application:  

IHC-P

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-R00439A
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-2116-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
loading...
    loading...